Skip to content

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block in Patients With Chronic Upper Extremity Neuropathic Pain: a Prospective Randomized and Comparative Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04876989
Enrollment
69
Registered
2021-05-07
Start date
2021-07-21
Completion date
2023-01-16
Last updated
2023-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Post Surgical Pain, Complex Regional Pain Syndromes, Neuropathic Pain, Phantom Limb Pain, Postherpetic Neuralgia, Post-Traumatic Neuralgia

Brief summary

The purpose of this study is to investigate the effect of ultrasound-guided thoracic paravertebral block (TPVB) when performing sympathetic block for upper limb pain control.

Detailed description

Well-trained pain physicians performs all US-guided stellate ganglion block(SGB)s or US-guided thoracic paravertebrl block(TPVB)s, who is not involved in evaluating study variables. Electrocardiography, noninvasive blood pressure, heart rate, and peripheral oxygen saturation were monitored for all patients before, while, and after conducting procedure. For US-guided SGB, patients are supine positioned, and skin preparation on injection site is done with chlorohexidine. Procedure is conducted under ultrasound guidance at C6 level. 5 ml of 1% mepivacaine is injected for the SGB group. Syringes are prepared by one nurse who do not involved in other steps of this study. For US-guided TPVB, patients are prone positioned, and skin preparation on injection site is done with chlorohexidine. Procedure is conducted under ultrasound guidance at T2 paravertebral space. 10 ml of 1% mepivacaine is injected for the TPVB group. Syringes are prepared by one nurse who do not involved in other steps of this study. Temperature measurement is conducted 2 times (before US-guided SGB or TPVB and after 20 minutes) at both hands by one person who's not involved in other measuring in the study.

Interventions

PROCEDUREUS-SGB

Well trained pain physician performs all the ultrasound(US)-guided stellate ganglion block(SGB)s, who is not involved in evaluating study variables. Electrocardiography, noninvasive blood pressure, heart rate, and peripheral oxygen saturation were monitored for all patients before, while, and after conducting procedure. For US-guided SGB, patients are supine positioned, and skin preparation on injection site is done with chlorohexidine. Procedure is conducted under ultrasound guidance at C6 level. 5 ml of 1% mepivacaine is injected for the US-SGB group.

PROCEDUREUS-TPVB

Well trained pain physician performs all the ultrasound(US)-guided thoracic paravertebral block(SGB)s, who is not involved in evaluating study variables. Electrocardiography, noninvasive blood pressure, heart rate, and peripheral oxygen saturation were monitored for all patients before, while, and after conducting procedure. For US-guided TPVB, patients are prone positioned, and skin preparation on injection site is done with chlorohexidine. Procedure is conducted under ultrasound guidance at T2 paravertebral space. 10 ml of 1% mepivacaine is injected for the US-TPVB group.

Sponsors

SMG-SNU Boramae Medical Center
CollaboratorOTHER
Seoul National University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of complex regional pain syndrome * Clinical diagnosis of postherpetic neuralgia * Clinical diagnosis of phantom limb pain * Clinical diagnosis of chronic post-surgical pain * Clinical diagnosis of post-traumatic pain syndrome * Upper extremity pain lasting more than 3 months Patients with a new or known diagnosis of chronic neuropathic pain lasting more than 3 months in the upper extremity

Exclusion criteria

* Refusal of a patient * Any vascular disease in the upper extremities * Previous history of thoracic sympathetic or stellate ganglion neurolysis (e.g. -thermocoagulation, radiofrequency neuromodulation, and/or chemical neurolysis) * Coagulopathy * Systemic infection or local infection at the needle injection site * Major deformation at the level of the neck (radiotherapy, surgery, etc.) * Known allergy to local anesthetics of amide type * Inability to understand a numeric rating pain scale (cognitive dysfunction) * Patients whose palm temperature on the ipsilateral side is ≥ 36.5℃ in the thermography before the procedure

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients reaching > 1.5°C rise of temperature in the ipsilateral hand compared to the contralateral hand20 minutes after US-guided thoracic paravertebral block or US-guided stellate ganglion blockTemperature is measured with a laser thermometer on the palmar aspect of 3 cm below from the middle finger.

Secondary

MeasureTime frameDescription
Difference of temperature change (°C) between ipsilateral hand and contralateral hand20 minutes after US-guided thoracic paravertebral block or US-guided stellate ganglion blockTemperature is measured with a laser thermometer on the palmar aspect of 3 cm below from the middle finger.
Severity of painTime before block and 20 minutes and 1 week and 4weeks after US-guided thoracic paravertebral block or US-guided stellate ganglion blockThe severity of the pain will be evaluated before the block and 20 minutes, 1 week and 4 weeks after the block using an 11-pointed NRS (numerical rating scale) pain score.
Patient global impression change (PGIC)Time 20 minutes and 1 week and 4 weeks after US-guided thoracic paravertebral block or US-guided stellate ganglion blockThe PGIC will be evaluated 20 minutes, 1 week and 4 weeks after the block using a 5-point Likert scale.
Comparison of Korean version CISS(Cold Intolerance Symptom Severity) QuestionnaireTime before block and 4 weeks after US-guided thoracic paravertebral block or US-guided stellate ganglion blockCheck the CISS before the procedure and 4 weeks after the procedure.
Blood flow velocity measurement in upper extremity vessel(ipsilateral brachial artery) using ultrasoundTime before block and 20minutes after US-guided thoracic paravertebral block or US-guided stellate ganglion blockThe blood flow velocity in the ipsilateral brachial artery will be measured before the block and 20 minutes after the block using a Doppler mode ultrasound device.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026